Regeneron Pharmaceuticals
A Senior Automation Engineer in Protein Expression Sciences leads the advancement and management of automated systems to support VelociMab antibody discovery and cell line development. The role focuses on driving innovation, improving efficiency of automated workflows, and collaborating across scientific and engineering teams to enable scalable laboratory automation solutions.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Associate Scientist
Bristol Myers Squibb
Principal Scientist, AI Protein Sciences (Discovery Platforms & Automation)
Systimmune
Senior Scientist I Protein Expression & Automation
Evotec
Protein Expression Scientist
AbbVie
Senior Scientist I Protein Expression & Automation
Evotec
Associate Director or Director of Protein Sciences
Systimmune